Cargando…

Molecular Characterization of the Response to Conventional Chemotherapeutics in Pro-B-ALL Cell Lines in Terms of Tumor Relapse

Little is known about optimally applying chemotherapeutic agents in a specific temporal sequence to rapidly reduce the tumor load and to improve therapeutic efficacy. The clinical optimization of drug efficacy while reducing side effects is still restricted due to an incomplete understanding of the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gladbach, Yvonne Saara, Sklarz, Lisa-Madeleine, Roolf, Catrin, Beck, Julia, Schütz, Ekkehard, Fuellen, Georg, Junghanss, Christian, Murua Escobar, Hugo, Hamed, Mohamed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316692/ https://www.ncbi.nlm.nih.gov/pubmed/35886023 http://dx.doi.org/10.3390/genes13071240

Ejemplares similares

Combination of the PI3K inhibitor Idelalisib with the conventional cytostatics cytarabine and dexamethasone leads to changes in pathway activation that induce anti-proliferative effects in B lymphoblastic leukaemia cell lines
por: Sklarz, L.-M., et al.
Publicado: (2020)

Combined Casein Kinase II inhibition and epigenetic modulation in acute B-lymphoblastic leukemia
por: Richter, Anna, et al.
Publicado: (2019)

Unraveling the Heterogeneous Mutational Signature of Spontaneously Developing Tumors in MLH1(−/−) Mice
por: Gladbach, Yvonne Saara, et al.
Publicado: (2019)

Comparative High-Resolution Transcriptome Sequencing of Lymphoma Cell Lines and de novo Lymphomas Reveals Cell-Line-Specific Pathway Dysregulation
por: Taher, Leila, et al.
Publicado: (2018)

FocusHeuristics – expression-data-driven network optimization and disease gene prediction
por: Ernst, Mathias, et al.
Publicado: (2017)

PDA Indolylmaleimides Induce Anti-Tumor Effects in Prostate Carcinoma Cell Lines Through Mitotic Death
por: Schille, Jan Torben, et al.
Publicado: (2021)

Polymorphisms of the murine mitochondrial ND4, CYTB and COX3 genes impact hematopoiesis during aging
por: Kretzschmar, Christin, et al.
Publicado: (2016)

Characterization of the novel indolylmaleimides' PDA-66 and PDA-377 effect on canine lymphoma cells
por: Liu, Wen, et al.
Publicado: (2016)

Evaluation of the Synergistic Potential of Simultaneous Pan- or Isoform-Specific BET and SYK Inhibition in B-Cell Lymphoma: An In Vitro Approach
por: Sender, Sina, et al.
Publicado: (2022)

Ultradeep targeted sequencing reveals low allele frequencies of somatic JAK2 and MPL variants in patients with abdominal vein thromboses: results of an ongoing prospective prevalence study in Mecklenburg-West Pomerania
por: Grunwald, Luise, et al.
Publicado: (2020)

Inbred mouse strains reveal biomarkers that are pro-longevity, antilongevity or role switching
por: Moeller, Mark, et al.
Publicado: (2014)

Phosphoproteome Analysis Reveals Differential Mode of Action of Sorafenib in Wildtype and Mutated FLT3 Acute Myeloid Leukemia (AML) Cells
por: Roolf, Catrin, et al.
Publicado: (2017)

Influence of Casein kinase II inhibitor CX-4945 on BCL6-mediated apoptotic signaling in B-ALL in vitro and in vivo
por: Richter, Anna, et al.
Publicado: (2020)

Kinetics of Langerhans cell chimerism in the skin of dogs following 2 Gy TBI allogeneic hematopoietic stem cell transplantation
por: Peters, Sabrina, et al.
Publicado: (2016)

Novel Isoquinolinamine and Isoindoloquinazolinone Compounds Exhibit Antiproliferative Activity in Acute Lymphoblastic Leukemia Cells
por: Roolf, Catrin, et al.
Publicado: (2019)

Combined Application of Pan-AKT Inhibitor MK-2206 and BCL-2 Antagonist Venetoclax in B-Cell Precursor Acute Lymphoblastic Leukemia
por: Richter, Anna, et al.
Publicado: (2021)

Evaluation of combination protocols of the chemotherapeutic agent FX-9 with azacitidine, dichloroacetic acid, doxorubicin or carboplatin on prostate carcinoma cell lines
por: Weiner, Franziska, et al.
Publicado: (2021)

In vivo vaccination with cell line-derived whole tumor lysates: neoantigen quality, not quantity matters
por: Salewski, Inken, et al.
Publicado: (2020)

A workflow for the integrative transcriptomic description of molecular pathology and the suggestion of normalizing compounds, exemplified by Parkinson’s disease
por: Hamed, Mohamed, et al.
Publicado: (2018)

The Molecular Subtype of Adult Acute Lymphoblastic Leukemia Samples Determines the Engraftment Site and Proliferation Kinetics in Patient-Derived Xenograft Models
por: Richter, Anna, et al.
Publicado: (2022)

Transfer learning of clinical outcomes from preclinical molecular data, principles and perspectives
por: Kowald, Axel, et al.
Publicado: (2022)

Decitabine demonstrates antileukemic activity in B cell precursor acute lymphoblastic leukemia with MLL rearrangements
por: Roolf, C., et al.
Publicado: (2018)

Towards biomarkers for outcomes after pancreatic ductal adenocarcinoma and ischaemic stroke, with focus on (co)-morbidity and ageing/cellular senescence (SASKit): protocol for a prospective cohort study
por: Henze, Larissa, et al.
Publicado: (2020)

Single-cell analyses of aging, inflammation and senescence
por: Uyar, Bora, et al.
Publicado: (2020)

Novel chemotherapeutic agent FX-9 activates NF-κB signaling and induces G1 phase arrest by activating CDKN1A in a human prostate cancer cell line
por: Weiner, F., et al.
Publicado: (2021)

RNA-seq of nine canine prostate cancer cell lines reveals diverse therapeutic target signatures
por: Packeiser, Eva-Maria, et al.
Publicado: (2022)

BTK and PI3K Inhibitors Reveal Synergistic Inhibitory Anti-Tumoral Effects in Canine Diffuse Large B-Cell Lymphoma Cells
por: Kong, Weibo, et al.
Publicado: (2021)

Analysis of Copy-Number Variations and Feline Mammary Carcinoma Survival
por: Granados-Soler, José Luis, et al.
Publicado: (2020)

Publisher Correction: Analysis of Copy-Number Variations and Feline Mammary Carcinoma Survival
por: Granados-Soler, José Luis, et al.
Publicado: (2020)

Validation of an LC–MS/MS Method for the Quantification of the CK2 Inhibitor Silmitasertib (CX-4945) in Human Plasma
por: Schwarz, Rico, et al.
Publicado: (2022)

An RNA-Seq-Based Framework for Characterizing Canine Prostate Cancer and Prioritizing Clinically Relevant Biomarker Candidate Genes
por: Thiemeyer, Heike, et al.
Publicado: (2021)

Combined BCL-2 and PI3K/AKT Pathway Inhibition in KMT2A-Rearranged Acute B-Lymphoblastic Leukemia Cells
por: Holz, Clemens, et al.
Publicado: (2023)

Prevalence of the Prefoldin Subunit 5 Gene Deletion in Canine Mammary Tumors
por: Hennecke, Silvia, et al.
Publicado: (2015)

Establishment and characterization of stable red, far-red (fR) and near infra-red (NIR) transfected canine prostate cancer cell lines
por: Liu, Wen, et al.
Publicado: (2020)

Precursor B-ALL Cell Lines Differentially Respond to SYK Inhibition by Entospletinib
por: Sender, Sina, et al.
Publicado: (2021)

Healthspan pathway maps in C. elegans and humans highlight transcription, proliferation/biosynthesis and lipids
por: Möller, Steffen, et al.
Publicado: (2020)

The novel arylindolylmaleimide PDA-66 displays pronounced antiproliferative effects in acute lymphoblastic leukemia cells
por: Kretzschmar, Christin, et al.
Publicado: (2014)

Spirooxindol‐1,3‐oxazine Alkaloids: Highly Potent and Selective Antitumor Agents Evolved from Iterative Structure Optimization
por: Eichhorst, Annika, et al.
Publicado: (2022)

A Simple LC-MS/MS Method for the Quantification of PDA-66 in Human Plasma
por: Schwarz, Rico, et al.
Publicado: (2022)

Suppression of the TGF-β pathway by a macrolide antibiotic decreases fibrotic responses by ocular fibroblasts in vitro
por: Stahnke, Thomas, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hv3uphso006tugu5efbd331lfo